November 19, 2024

Music and Mind Series - Part 5 with Renée Fleming: Harnessing the Arts for Health and Wellness

Music and Mind Series - Part 5 with Renée Fleming: Harnessing the Arts for Health and Wellness

About This Episode

Music and the arts have a positive impact on brain health, mental well-being, and quality of life. Renée Fleming, World Renowned Soprano and Global Arts Health Advocate shares the latest science behind the healing power of music and the brain with BrainStorm host Meryl Comer. 

Fleming’s anthology, Music and Mind: Harnessing the Arts for Health and Wellness, is a collection of essays about the powerful impact of music on health and human experiences, particularly how it plays a critical role to help preserve memory. In part 2 of the interview Fleming discusses the need for greater integration of the arts into the healthcare system and the role AI can play in advancing music related medical research.  You won’t want to miss this conversation highlighting the intersection of art, music, and science.

Support for BrainStorm by UsAgainstAlzheimer’s is provided by Eisai

Support the show

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW